These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15077195)

  • 21. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Casein kinase I epsilon associates with and phosphorylates the tight junction protein occludin.
    McKenzie JA; Riento K; Ridley AJ
    FEBS Lett; 2006 Apr; 580(9):2388-94. PubMed ID: 16616143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.
    Mishra SK; Talukder AH; Gururaj AE; Yang Z; Singh RR; Mahoney MG; Francí C; Vadlamudi RK; Kumar R
    J Biol Chem; 2004 Jul; 279(31):32709-15. PubMed ID: 15169784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
    Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
    Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
    Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
    Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine neurofilament-enriched preparations contain kinase activity similar to casein kinase I--neurofilament phosphorylation by casein kinase I (CKI).
    Link WT; Dosemeci A; Floyd CC; Pant HC
    Neurosci Lett; 1993 Mar; 151(1):89-93. PubMed ID: 8385762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phosphatidylinositol 4,5-bisphosphate-sensitive casein kinase I alpha associates with synaptic vesicles and phosphorylates a subset of vesicle proteins.
    Gross SD; Hoffman DP; Fisette PL; Baas P; Anderson RA
    J Cell Biol; 1995 Aug; 130(3):711-24. PubMed ID: 7622570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
    Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
    Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner.
    Wilson BJ; Bates GJ; Nicol SM; Gregory DJ; Perkins ND; Fuller-Pace FV
    BMC Mol Biol; 2004 Aug; 5():11. PubMed ID: 15298701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain.
    Toyama T; Iwase H; Yamashita H; Hara Y; Sugiura H; Zhang Z; Fukai I; Miura Y; Riabowol K; Fujii Y
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):57-63. PubMed ID: 14630091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor.
    Arnold SF; Obourn JD; Jaffe H; Notides AC
    Mol Endocrinol; 1994 Sep; 8(9):1208-14. PubMed ID: 7838153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.